section name header

Pronunciation ⬇

trye-am-SIN-oh-lone

Classifications ⬆ ⬇

Therapeutic Classification: corticosteroids

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

  • Potent, locally acting anti-inflammatory and immune modifier.
Therapeutic effects:
  • Decrease in symptoms of allergic rhinitis.

Pharmacokinetics ⬆ ⬇

Absorption: Action of all agents is primarily local after nasal use.

Distribution: Crosses the placenta and enters breast milk in small amounts.

Metabolism/Excretion: Rapidly and extensively metabolized by the liver; 40% excreted in urine, 60% in feces.

Half-Life: 3–5.4 hr.

Time/Action Profile ⬆ ⬇

(improvement in symptoms)

ROUTEONSETPEAKDURATION
Intranasalfew days3–4 daysunknown

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

EENT: epistaxis, nasal burning, nasal irritation, nasopharyngeal fungal infection, otitis media, pharyngitis, rhinitis, sinusitis, sneezing

Endo: adrenal suppression (high-dose, long-term therapy only)

GI: vomiting

Neuro: headache

Resp: cough

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Nasacort Allergy 24 HR

Canadian Brand Names ⬆ ⬇

Nasacort AQ

Code ⬆

NDC Code